ChartRow logo
ChartRow
Stocks and ETFs
Sign in
GILD
Gilead Sciences Inc.Stock · Healthcare
$131.27+$5.30 (+4.21%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

How Gilead Sciences makes money

Fiscal year

How does Gilead Sciences make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year. Straight from SEC filings.

Gilead Sciences Inc. · FY2025 · year ended 2025-12-31
Revenue$29.4BGross profit$23.2B · 79%Cost of revenue$6.2B · 21%Operating income$10.0B · 34%Operating expenses$13.2B · 45%R&D$5.8B · 20%SG&A$5.8B · 20%Other opex$1.6B · 5%Pre-tax income$9.8B · 33%Other expense$226M · 1%Net income$8.5B · 29%Income tax$1.3B · 4%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.